Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study comparing Vicagrel capsules with Clopidogrel tablets in healthy CYP2C19 normal metabolizers has been completed to characterize pharmacokinet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Vicagrel (vicagrel)

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Acute Coronary Syndrome | Phase 1 | Status: COMPLETED